Nov 10, 2022 / 09:30PM GMT
Operator
Good day, and welcome to the OncoCyte conference call to discuss the third quarter 2022 financial results. Today's call is being recorded.
At this time, I would like to turn the call over to Caroline Corner, Westwicke Investor Relations. Please go ahead.
Caroline V. Corner - Westwicke Partners, LLC - MD
Thank you, operator, and thank you, everyone, for joining us for today's conference call to discuss OncoCyte's third quarter 2022 financial results. If you have not seen today's financial results press release, please visit the company's website on the Investors page.
Joining me on today's call are Ronnie Andrews, President and Chief Executive Officer; and Anish John, Chief Financial Officer.
I would like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. Any statements that are not historical facts are forward-looking statements. We encourage you to review the company's SEC filings, including, without limitation, the company's Form 10-K and 10-Q,
Q3 2022 OncoCyte Corp Earnings Call Transcript
Nov 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers